Convective and diffusive losses of vitamin C during haemodiafiltration session: a contributive factor to oxidative stress in haemodialysis patients

被引:139
作者
Morena, M
Cristol, JP
Bosc, JY
Tetta, C
Forret, G
Leger, CL
Delcourt, C
Papoz, L
Descomps, B
Canaud, B
机构
[1] Univ Montpellier I, Lapeyronie Hosp, Dept Biochem, F-34295 Montpellier, France
[2] Univ Montpellier I, Lapeyronie Hosp, Dept Nephrol, F-34295 Montpellier, France
[3] Bellco SpA, Clin & Lab Res Dept, Mirandola, Italy
[4] INSERM, U500, Unite Epidemiol Malad Chron & Vieillissement, Montpellier, France
关键词
antioxidant; haemodiafiltration; oxidative stress; vitamin C;
D O I
10.1093/ndt/17.3.422
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Enhanced oxidative stress in haemodialysis (HD) patients may be considered as a risk factor for accelerated atherosclerosis. Reduced antioxidant defences include impairment in enzyme activities and decreased plasma levels of hydrophilic vitamin C (vit C), and cellular levels of lipophilic vitamin E (vit E). Methods. We investigated plasma levels of vit C in 19 patients undergoing regular haemodiafiltration (HDF) (mean age 62 +/- 7 years) and in 1846 healthy elderly subjects (HS) (mean age 69 +/- 5 years). The contribution of convection and diffusion was determined using paired filtration dialysis (PFD), a modified HDF technique which physically separates convective from diffusive fluxes. Blood samples were collected before and after the HDF session; in addition at 60 min of HDF, samples were drawn from arterial lines (AL) and venous lines (VL), dialysate (D) and ultrafiltrate (UF). Blood levels of total vit C were determined using an HPLC fluorescence method. Markers of oxidative stress were also assessed in both populations as follows: levels of malondialdehyde (MDA) were determined by fluorometric assay, measurements of advanced oxidation protein products (AOPP) and glutathione peroxidase (GSH-Px) activity were performed by spectrophotometric assay, and plasma vit E content was obtained by an HPLC procedure. Results. A significant reduction in plasma vit C level was observed in HDF patients when compared with HS (1.6 +/- 1.4 mug/ml in HDF vs 6.6 +/- 3.7 mug/ml in HS; P<0.01). The HDF session was associated with a dramatic reduction in vit C levels (1.87 +/- 1.57 mu g/ml before HDF and 0.98 +/- 0.68 mu g/ml after HDF); at 60 min of HDF, concentrations were as follows: AL = 1.35 +/- 1.27 mu g/ml; VL = 0.37 +/- 0.31 mu g/ml, D = 0.40 +/- 0.34 mu g/ml, UF = 1.24 +/- 1.18 mu g/ml; corresponding, to a diffusive flux of 271 mu g/min and a convective flux of 126 mu g/min. Total loss of vit C could be assessed at 66 mg/session (8-230 mg/session). According to this loss of vit C, presence of an oxidative stress was demonstrated in HD population as shown by a significant increase in MDA (1.66 +/- 0.27 mu M in HD vs 0.89 +/- 0.25 mu M in HS; P < 0.01) and AOPP (77.5 +/- 29.3 muM in HD vs 23.5 +/- 13.2 muM in HS; P<0.01) levels, and a decrease in GSH-Px activity (259.2 +/- 106.3 U/l in HD vs 661.2 +/- 92.2 U/l in HS; P<0.01). No change in plasma vit E between both populations (30.7 +/- 9.1 muM in HD vs 35.3 +/- 7.34 muM in HS) was observed. Conclusions. These results suggest that HDF with highly permeable membranes is associated with a significant loss of vit C. Diffusive transport is responsible for two-thirds whereas convective phenomenon accounts for only one-third of this loss.
引用
收藏
页码:422 / 427
页数:6
相关论文
共 38 条
[21]  
PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
[22]  
PANZETTA O, 1995, CLIN NEPHROL, V44, P303
[23]   SERUM AND ERYTHROCYTE TOCOPHEROL IN UREMIC PATIENTS - EFFECT OF HEMODIALYSIS VERSUS PERITONEAL-DIALYSIS [J].
PASTOR, MC ;
SIERRA, C ;
BONAL, J ;
TEIXIDO, J .
AMERICAN JOURNAL OF NEPHROLOGY, 1993, 13 (04) :238-243
[24]   LIPID-PEROXIDATION ABNORMALITIES IN HEMODIALYZED PATIENTS [J].
PAUL, JL ;
SALL, ND ;
SONI, T ;
POIGNET, JL ;
LINDENBAUM, A ;
MAN, NK ;
MOATTI, N ;
RAICHVARG, D .
NEPHRON, 1993, 64 (01) :106-109
[25]  
PONKA A, 1983, ACTA MED SCAND, V213, P1339
[26]   VITAMIN-C INTOXICATION AND HYPEROXALEMIA IN CHRONIC-HEMODIALYSIS PATIENTS [J].
PRU, C ;
EATON, J ;
KJELLSTRAND, C .
NEPHRON, 1985, 39 (02) :112-116
[27]   TRACE-ELEMENTS AND LIPID-PEROXIDATION ABNORMALITIES IN PATIENTS WITH CHRONIC-RENAL-FAILURE [J].
RICHARD, MJ ;
ARNAUD, J ;
JURKOVITZ, C ;
HACHACHE, T ;
MEFTAHI, H ;
LAPORTE, F ;
FORET, M ;
FAVIER, A ;
CORDONNIER, D .
NEPHRON, 1991, 57 (01) :10-15
[28]  
SAINTGEORGES MD, 1989, KIDNEY INT, V36, pS274
[29]   Low density lipoprotein (LDL) modification: Basic concepts and relationship to atherosclerosis [J].
Sevanian, A ;
Asatryan, L ;
Ziouzenkova, O .
BLOOD PURIFICATION, 1999, 17 (2-3) :66-78
[30]  
SULLIVAN JF, 1970, AM J CLIN NUTR, V23, P1339